Beth Israel Deaconess Medical Center, Inc.

Sharon Maynard

Vikas P Sukhatme

S Ananth Karumanchi

Ananth S Karumanchi

Disclosed herein are methods for treating pre-eclampsia and eclampsia using compounds that increase VEGF or PlGF levels or compounds that decrease sFlt-1 levels. Compounds that inhibit the binding of VEGF or PlGF to sFlt1- are also disclosed herein for the treatment of pre-eclampsia or eclampsia.

Methods of treating pre-eclampsia or eclampsia

Disclosed herein are methods for diagnosing pre-eclampsia and eclampsia. Also disclosed herein are methods for treating pre-eclampsia and eclampsia using compounds that increase VEGF or PlGF levels or compounds that decrease sFlt-1 levels. Compounds that inhibit the binding of VEGF or PlGF to sFlt1- are also disclosed herein for the treatment of pre-eclampsia or eclampsia.

Methods of diagnosing pre-eclampsia or eclampsia

Disclosed herein are methods for diagnosing pre-eclampsia and eclampsia. Also disclosed herein are methods for treating pre-eclampsia and eclampsia using compounds that increase VEGF or PlGF levels or compounds that decrease sFlt-1 levels. Compounds that inhibit the binding of VEGF or PlGF to sFlt1&#x2014;are also disclosed herein for the treatment of pre-eclampsia or eclampsia.

Growing community of inventors

Newton, MA, United States of America

Sharon Maynard